Kurs & Likviditet
Beskrivning
Land | Norge |
---|---|
Lista | OB Match |
Sektor | Hälsovård |
Industri | Bioteknik |
2023-10-25 15:32:37
Oslo, Norway, October 25, 2023- Datum AS has today acquired 500,000 shares in
Nykode Therapeutics ASA at an average price of NOK 17.82 per share. Harald Arnet
is the CEO of Datum AS and is a Member of the Board of Directors and primary
insider in Nykode Therapeutics ASA. Following the transaction Datum AS holds
12,560,250 shares in the company.
For further details, please see the attached form.